HMA MANAGEMENT GROUP
The Heads of Medicines Agencies (HMA) Management Group, as endorsed during the Irish Presidency in 2004, has as its main-objectives the co-ordination and facilitation of the operation of HMA, and the supervision and management of the HMA Permanent Secretariat.
The current composition of the HMA Management Group is:
- María Jesús Lamas Díaz (AEMPS, Spain) - Chair | biography
- Momir Radulović (JAZMP, Slovenia) - Vice Chair| biography
- Thomas Heberer (BVL, Germany) | biography
- J. Gabriel Beechinor (HPRA, Ireland) | biography
- Rui Santos Ivo (INFARMED, Portugal) | biography
- Günter Waxenecker (AGES, Austria) | biography
- Karl Broich (BfArM, Germany) | biography
- Aimad Torqui - co-opted (CBG-MEB, Netherlands) | biography
- Presidency of the EU Council: Poland |
HMA PERMANENT SECRETARIAT
The HMA Permanent Secretariat (HMA PS) is the team of appointed international advisers from six national competent authorities. They are strategy partners to HMA Management Group. The HMA PS translates HMA & HMA MG strategic initiatives into operational results by driving execution, collaboration and progress on the initiatives across all Heads of Medicines Agencies.
The team is:
Amapola Claudia de la Cámara (AEMPS, Spain) | LinkedIn
David Obranovič (JAZMP, Slovenia) |
Marta Toma (AIFA, Italy ) | LinkedIn
Hannes Eintrei (SMPA, Sweden) | LinkedIn
Annalise Attard (MMA, Malta) | LinkedIn
Birgitte Faber (DKMA, Denmark) | LinkedIn
In case of queries, please contact us: ps@hma.eu